Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,995 public trials 744 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease

NCT02573870

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Hollywood, Florida, United States
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
View Trial Details
Completed

Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial

NCT02972476

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • NHS Tayside Dundee, Tayside, United Kingdom
  • Blackpool Teaching Hospital NHS Foundation Trust Blackpool, United Kingdom
  • NHS Lothian Edinburgh, United Kingdom
  • NHS Greater Glasgow and Clyde Glasgow, United Kingdom
View Trial Details
Completed

Prevalence of Asthma and Allergies Among Children in UAE

NCT03878680

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Ajman, United Arab Emirates
  • Research Site Dubai, United Arab Emirates
  • Research Site FUJ, United Arab Emirates
  • Research Site Ras al-Khaimah, United Arab Emirates
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD)

NCT03359473

Conditions
Body Weight, Body Weight Changes, Cachexia, +17 more
Locations
  • GSK Investigational Site Torrance, California, United States
  • GSK Investigational Site Jacksonville, Florida, United States
  • GSK Investigational Site High Point, North Carolina, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions